Search Login Register

UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase Summary

3 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: consider also EC 2.4.1.92

Also Known As: (1-4)-N-acetyl-beta-D-galactosaminyltransferase; 4-GalNActransferase; GalNAcT-1; UDP-N-acetylgalactosamine-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase; beta-1,4-N-acetylgalactosaminyltransferase Show All >>

Key Diseases for which UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase is Relevant

  1. Neoplasms (Cancer) : 2 results
  2. Experimental Melanoma : 1 result
  3. Melanoma (Melanoma, Malignant) : 1 result
  4. Intestinal Neoplasms (Intestinal Cancer) : 1 result
  5. Colonic Neoplasms (Colon Cancer) : 1 result
Show All >>

Drugs Related to UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase

  1. Complementary DNA (cDNA)
  2. Messenger RNA (mRNA)
  3. Gangliosides
  4. G(M3) Ganglioside
  5. Antigens

Therapies Related to UDP-GalNAc-beta-galactose beta 1,4-N-acetylgalactosaminyltransferase


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.